Bolden Therapeutics
Dr. Valat completed a double MSc program from the Université Grenoble Alpes (France), one in Bioengineering, biomedical instrumentation and implantable biomaterials, and the other in Nanosciences and nanobiotechnology. She also completed her PhD in biomaterials and biomechanics also from the Université Grenoble Alpes. She carried out her postdoctoral research at in the Kaplan Lab at Tufts University, working on combining cellular therapy and silk-based materials for the treatment of neurodegenerative diseases.
This person is not in any teams
This person is not in any offices
Bolden Therapeutics
1 followers
Bolden Therapeutics is a biotechnology company developing first-in-class therapeutics to treat central nervous system diseases such as Alzheimer’s and ischemic stroke.